European Archives of Psychiatry and Clinical Neuroscience

Papers
(The median citation count of European Archives of Psychiatry and Clinical Neuroscience is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Associations between COVID-19 related media consumption and symptoms of anxiety, depression and COVID-19 related fear in the general population in Germany219
Mental health effects of infection containment strategies: quarantine and isolation—a systematic review and meta-analysis131
Subjective burden and perspectives of German healthcare workers during the COVID-19 pandemic97
Transcranial alternating current stimulation (tACS): from basic mechanisms towards first applications in psychiatry96
Decreased utilization of mental health emergency service during the COVID-19 pandemic83
Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor75
Missed diagnoses and misdiagnoses of adults with autism spectrum disorder75
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life60
Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations56
The COVID-19 pandemic brings a second wave of social isolation and disrupted services50
Dementia is a predictor for mortality outcome from coronavirus disease 2019 (COVID-19) infection43
Cognitive impairment in people with schizophrenia: an umbrella review40
Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions39
Association of herpes zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study37
Psychological and neuropsychiatric implications of COVID-1937
Cognitive decline following acute viral infections: literature review and projections for post-COVID-1936
Upscaling e-mental health in Europe: a six-country qualitative analysis and policy recommendations from the eMEN project32
Serum zonulin and claudin-5 levels in patients with schizophrenia32
Association between tDCS computational modeling and clinical outcomes in depression: data from the ELECT-TDCS trial30
Psychological trauma as a transdiagnostic risk factor for mental disorder: an umbrella meta-analysis29
Longitudinal determination of resilience in humans to identify mechanisms of resilience to modern-life stressors: the longitudinal resilience assessment (LORA) study28
Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling27
Concomitant lorazepam use and antidepressive efficacy of repetitive transcranial magnetic stimulation in a naturalistic setting26
Double bookkeeping and schizophrenia spectrum: divided unified phenomenal consciousness26
Peripandemic psychiatric emergencies: impact of the COVID-19 pandemic on patients according to diagnostic subgroup26
P2X7R antagonists in chronic stress-based depression models: a review26
The German Guidelines for the treatment of anxiety disorders: first revision24
The role of microglia in neuropsychiatric disorders and suicide24
One year after the COVID-19 outbreak in Germany: long-term changes in depression, anxiety, loneliness, distress and life satisfaction23
Functional near-infrared spectroscopy (fNIRS) as a tool to assist the diagnosis of major psychiatric disorders in a Chinese population22
Longitudinal effects of rTMS on neuroplasticity in chronic treatment-resistant depression22
Online therapy: an added value for inpatient routine care? Perspectives from mental health care professionals22
Inflammatory cytokines derived from peripheral blood contribute to the modified electroconvulsive therapy-induced cognitive deficits in major depressive disorder22
Social isolation and psychosis: an investigation of social interactions and paranoia in daily life20
The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia20
Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies19
Relapse in patients with serious mental disorders during the COVID-19 outbreak: a retrospective chart review from a community mental health center18
Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients17
From economic crisis to the COVID-19 pandemic crisis: evidence from a mental health helpline in Greece17
Inflammation, hippocampal volume, and cognition in schizophrenia: results from the Northern Finland Birth Cohort 196617
Microglial depletion and abnormalities in gut microbiota composition and short-chain fatty acids in mice after repeated administration of colony stimulating factor 1 receptor inhibitor PLX562217
Combined antisaccade task and transcranial direct current stimulation to increase response inhibition in binge eating disorder17
Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state17
Old drug fluvoxamine, new hope for COVID-1917
The relationship between cortisol reactivity and emotional brain function is differently moderated by childhood trauma, in bipolar disorder, schizophrenia and healthy individuals17
Functional near-infrared spectroscopy in developmental psychiatry: a review of attention deficit hyperactivity disorder16
Beyond physiotherapy and pharmacological treatment for fibromyalgia syndrome: tailored tACS as a new therapeutic tool16
Prevalence and clinical demography of hyperhomocysteinemia in Han Chinese patients with schizophrenia15
Evolution of psychosocial burden and psychiatric symptoms in patients with psychiatric disorders during the Covid-19 pandemic15
Aerobic exercise in severe mental illness: requirements from the perspective of sports medicine15
Arketamine for cognitive impairment in psychiatric disorders15
Co-occurrence of severe PTSD, somatic symptoms and dissociation in a large sample of childhood trauma inpatients: a network analysis15
Clinical characterization of brief psychotic disorders triggered by the COVID-19 pandemic: a multicenter observational study15
Effects of bifrontal transcranial direct current stimulation on brain glutamate levels and resting state connectivity: multimodal MRI data for the cathodal stimulation site15
Mental health treatment online during the COVID-19 outbreak15
Limbic links to paranoia: increased resting-state functional connectivity between amygdala, hippocampus and orbitofrontal cortex in schizophrenia patients with paranoia15
The societal cost of treatment-seeking patients with borderline personality disorder in Germany14
High-intensity interval training and active video gaming improve neurocognition in schizophrenia: a randomized controlled trial14
Enhancement of aerobic fitness improves social functioning in individuals with schizophrenia14
Characteristics associated with self-reported medication adherence in persons with psychosis referred to psychosocial rehabilitation centers13
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries13
Gut–microbiota–brain axis in the vulnerability to psychosis in adulthood after repeated cannabis exposure during adolescence13
Three types of psychotic-like experiences in youth at clinical high risk for psychosis13
Changes in functional connectivity after theta-burst transcranial magnetic stimulation for post-traumatic stress disorder: a machine-learning study12
Supporting employees with mental illness and reducing mental illness-related stigma in the workplace: an expert survey12
Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia12
Long-lasting cognitive effects of COVID-19: is there a role of BDNF?12
Advancing clinical response characterization to frontotemporal transcranial direct current stimulation with electric field distribution in patients with schizophrenia and auditory hallucinations: a pi12
Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia12
Association between chemosensory impairment with neuropsychiatric morbidity in post-acute COVID-19 syndrome: results from a multidisciplinary cohort study12
Rate of continuing acute course treatment using right unilateral ultrabrief pulse electroconvulsive therapy at a large academic medical center12
Peripheral biomarkers to predict the diagnosis of bipolar disorder from major depressive disorder in adolescents11
Association between formal thought disorders, neurocognition and functioning in the early stages of psychosis: a systematic review of the last half-century studies11
Metacognitive training for psychosis (MCT): past, present, and future11
ADHD symptom profiles, intermittent explosive disorder, adverse childhood experiences, and internalizing/externalizing problems in young offenders11
A network analysis of interoception, self-awareness, empathy, alexithymia, and autistic traits11
Deconstructing emotion regulation in schizophrenia: the nature and consequences of abnormalities at the identification stage11
Racism and psychosis: an umbrella review and qualitative analysis of the mental health consequences of racism11
Factors associated with lifetime suicide attempts in bipolar disorder: results from an Italian nationwide study11
FMRI-based prediction of naltrexone response in alcohol use disorder: a replication study11
Medium-term and peri-lockdown course of psychosocial burden during the ongoing COVID-19 pandemic: a longitudinal study on patients with pre-existing mental disorders11
Increased regional homogeneity modulated by metacognitive training predicts therapeutic efficacy in patients with schizophrenia11
Neurological soft signs and cognition in the late course of chronic schizophrenia: a longitudinal study11
Effects of treatment refractoriness and brain-derived neurotrophic factor Val66Met polymorphism on antidepressant response to low-dose ketamine infusion11
The weaker sex? What we can learn from sex differences in population mental health during and beyond the COVID-19 pandemic10
Exposure to common infections and risk of suicide and self-harm: a longitudinal general population study10
Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study10
C1q, a small molecule with high impact on brain development: putative role for aging processes and the occurrence of Alzheimer’s disease10
Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia10
Cognitive and functional deficits are associated with white matter abnormalities in two independent cohorts of patients with schizophrenia10
Neural basis of shame and guilt experience in women with borderline personality disorder10
Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts10
Social zeitgebers and circadian dysrhythmia are associated with severity of symptoms of PTSD and depression in trauma-affected refugees10
Frontal–striatal connectivity and positive symptoms of schizophrenia: implications for the mechanistic basis of prefrontal rTMS10
Optical coherence tomography reveals retinal thinning in schizophrenia spectrum disorders10
Movement markers of schizophrenia: a detailed analysis of patients’ gait patterns10
Anger and aggressiveness in obsessive–compulsive disorder (OCD) and the mediating role of responsibility, non-acceptance of emotions, and social desirability10
Neurological and psychiatric presentations associated with COVID-1910
BDNF influences neural cue-reactivity to food stimuli and food craving in obesity10
Repeated intermittent administration of (R)-ketamine during juvenile and adolescent stages prevents schizophrenia-relevant phenotypes in adult offspring after maternal immune activation: a role of Trk10
Characterizing the sensorimotor domain in schizophrenia spectrum disorders10
Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report10
The clinical relevance of formal thought disorder in the early stages of psychosis: results from the PRONIA study9
The link between Toxoplasma gondii infections and higher mortality in COVID-19 patients having schizophrenia9
Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia9
Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality9
ASD symptoms in adults with ADHD: a preliminary study using the ADOS-29
Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability9
Aberrant brain network topology in the frontoparietal-limbic circuit in bipolar disorder: a graph-theory study9
Suicidality in psychiatric emergency department situations during the first and the second wave of COVID-19 pandemic9
Improvement in daily functioning after aerobic exercise training in schizophrenia is sustained after exercise cessation9
Differential psychological response to the COVID-19 pandemic in psychiatric inpatients compared to a non-clinical population from Germany9
The role of neurotropism in psychiatric patients with COVID-199
A cross-sectional study on the mental health of patients with COVID-19 1 year after discharge in Huanggang, China9
A living meta-ecological study of the consequences of the COVID-19 pandemic on mental health9
Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals9
FAAH polymorphism (rs324420) modulates extinction recall in healthy humans: an fMRI study9
The percentage and clinical correlates of alexithymia in stable patients with schizophrenia9
Cognitive, community functioning and clinical correlates of the Clinical Assessment Interview for Negative Symptoms (CAINS) in psychotic disorders9
Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study9
Digital technology in psychiatry: towards the implementation of a true person-centered care in psychiatry?9
The impact of physical fitness on resilience to modern life stress and the mediating role of general self-efficacy9
Characterising cognitive heterogeneity in individuals at clinical high-risk for psychosis: a cluster analysis with clinical and functional outcome prediction9
Shared and distinct reward neural mechanisms among patients with schizophrenia, major depressive disorder, and bipolar disorder: an effort-based functional imaging study8
Predicting treatment outcome in depression: an introduction into current concepts and challenges8
Borderline personality disorder classification based on brain network measures during emotion regulation8
Mental health and the effects on methylation of stress-related genes in front-line versus other health care professionals during the second wave of COVID-19 pandemic: an Italian pilot study8
Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional intervention8
Cost-effectiveness of Alzheimer’s disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis8
Differential neural processing of unpleasant sensory stimulation in patients with major depression8
Reduced habenular volumes and neuron numbers in male heroin addicts: a post-mortem study8
Reduced number of satellite oligodendrocytes of pyramidal neurons in layer 5 of the prefrontal cortex in schizophrenia8
Aerobic endurance training to improve cognition and enhance recovery in schizophrenia: design and methodology of a multicenter randomized controlled trial8
Childhood adversity, adulthood adversity and suicidal ideation in Chinese patients with major depressive disorder: in line with stress sensitization8
mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development8
Palliative and high-intensity end-of-life care in schizophrenia patients with lung cancer: results from a French national population-based study8
Autistic traits as predictors of persistent depression7
ADHD prevalence in patients with hypersexuality and paraphilic disorders: a systematic review and meta-analysis7
Association between thyroid function and comorbid anxiety in first-episode and drug naïve patients with major depressive disorder7
Psychiatric emergency services and non-acute psychiatric services utilization during COVID-19 pandemic7
A pilot investigation of accelerated deep transcranial magnetic stimulation protocols in treatment-resistant depression7
Melancholic features (DSM-IV) predict but do not moderate response to antidepressants in major depression: an individual participant data meta-analysis of 1219 patients7
Changes in the pattern of suicides and suicide attempt admissions in relation to the COVID-19 pandemic7
The neural correlates of the visual consciousness in schizophrenia: an fMRI study7
Psychotropic drugs for the treatment of non-suicidal self-injury in children and adolescents: a systematic review and meta-analysis7
Inflammatory processes linked to major depression and schizophrenic disorders and the effects of polypharmacy in psychiatry: evidence from a longitudinal study of 279 patients under therapy7
Real-time cognitive performance and positive symptom expression in schizophrenia6
Common and distinct patterns of gray matter alterations in young adults with borderline personality disorder and major depressive disorder6
Correction to: Associations between COVID-19 related media consumption and symptoms of anxiety, depression and COVID-19 related fear in the general population in Germany6
Functional and clinical outcomes of FMRI-based neurofeedback training in patients with alcohol dependence: a pilot study6
The challenge of mental health during Covid-19 outbreak: experience from metropolitan area of Milan6
A 2-year longitudinal study of neuropsychological functioning, psychosocial adjustment and rehospitalisation in schizophrenia and major depression6
Fatigue and brain arousal in patients with major depressive disorder6
The impact of COVID-19-related distress on levels of depression, anxiety and quality of life in psychogeriatric patients6
An international clozapine titration guideline to increase its safety and move forward on the route started by German-speaking psychiatrists in the 1960s6
Meta-analysis of cognitive functioning in patients with psychotic disorders and obsessive–compulsive symptoms6
Effects of psychological treatments on functioning in people with Schizophrenia: a systematic review and meta-analysis of randomized controlled trials6
Males and females with first episode psychosis present distinct profiles of social cognition and metacognition6
Depressive symptoms in youth with ADHD: the role of impairments in cognitive emotion regulation6
Religiosity and prevalence of suicide, psychiatric disorders and psychotic symptoms in the French general population6
Monitoring medication response in ADHD: what can continuous performance tests tell us?6
Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination6
Effects of body-oriented yoga: a RCT study for patients with major depressive disorder6
Temporal and time–frequency features of auditory oddball response in distinct subtypes of patients at clinical high risk for psychosis6
A clinical investigation of psychotic vulnerability in early-onset Obsessive–Compulsive Disorder through Cognitive–Perceptive basic symptoms6
Cannabis use influence on peripheral brain-derived neurotrophic factor levels in antipsychotic-naïve first-episode psychosis6
Association of high BMI with subclinical hypothyroidism in young, first-episode and drug-naïve patients with major depressive disorder: a large-scale cross-sectional study6
Two-stage mental health survey of first-line medical staff after ending COVID-19 epidemic assistance and isolation6
Anomalous self-experiences are related to general cognition deficits in schizophrenia6
A cross-sectional survey of internet use among university students6
Emerging findings of glutamate–glutamine imbalance in the medial prefrontal cortex in attention deficit/hyperactivity disorder: systematic review and meta-analysis of spectroscopy studies6
The complex interaction of genetics and delirium: a systematic review and meta-analysis6
Mapping Research Domain Criteria using a transdiagnostic mini-RDoC assessment in mental disorders: a confirmatory factor analysis6
Reliability of neural food cue-reactivity in participants with obesity undergoing bariatric surgery: a 26-week longitudinal fMRI study6
First episode psychosis: register-based study of comorbid psychiatric disorders and medications before and after6
Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia6
Conversational metrics, psychopathological dimensions and self-disturbances in patients with schizophrenia6
Acute effects of ketamine on the pregenual anterior cingulate: linking spontaneous activation, functional connectivity, and glutamate metabolism6
Antidepressant effect of repetitive transcranial magnetic stimulation is not impaired by intake of lithium or antiepileptic drugs6
Effect of standardized post-coercion review session on symptoms of PTSD: results from a randomized controlled trial6
Efficacy of cognitive behavioural therapy in medicated adults with attention-deficit/hyperactivity disorder in multiple dimensions: a randomised controlled trial6
Reduced ribosomal DNA transcription in the prefrontal cortex of suicide victims: consistence of new molecular RT-qPCR findings with previous morphometric data from AgNOR-stained pyramidal neurons5
Metabolic parameters and thyroid hormones in relation to suicide attempts in patients with first-episode and drug-naive major depressive disorder with comorbid glucose disturbances: a large cross-sect5
Hub-connected functional connectivity within social brain network weakens the association with real-life social network in schizophrenia patients5
Diagnostic progression to schizophrenia in 35,255 patients with obsessive–compulsive disorder: a longitudinal follow-up study5
The prevention of suicide among military veterans during the COVID-19 pandemic5
Esmethadone-HCl (REL-1017): a promising rapid antidepressant5
Relationship of subjective quality of life with symptomatology, neurocognition and psychosocial functioning in first-episode psychosis: a structural equation modelling approach5
Depression and suicide attempts in Chinese adolescents with mood disorders: the mediating role of rumination5
Is twice daily LF-rTMS a viable treatment option for treatment-resistant OCD? Results from an open-label feasibility study5
Repeated bullying at the workplace in medical students and young doctors: the MESSIAEN national study5
The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials5
Hostility in medication-resistant major depression and comorbid generalized anxiety disorder is related to increased hippocampal–amygdala 5-HT2A receptor density5
Family therapy for persons with schizophrenia: neglected yet important5
Treatment of major depressive disorder with bilateral theta burst stimulation: study protocol for a randomized, double-blind, placebo-controlled multicenter trial (TBS-D)5
Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children5
Resting state functional connectivity and structural abnormalities of the brain in acute retarded catatonia: an exploratory MRI study5
Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data5
Extracellular vesicle approach to major psychiatric disorders5
Characterizing the features and course of psychiatric symptoms in children and adolescents with autoimmune encephalitis5
Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?5
Elevated levels of serotonin 5-HT2A receptors in the orbitofrontal cortex of antisocial individuals5
Neural signature of error processing in major depression5
A symptom-based approach in predicting ECT outcome in depressed patients employing MADRS single items5
Sex differences in prevalence and clinical correlates of insomnia in Chinese patients with chronic schizophrenia5
Antipsychotic drug dose in real-life settings results from a Nationwide Cohort Study5
Synergistic effect of chronic pain and nonsuicidal self-harm on pain sensitivity5
The course of attention-deficit/hyperactivity disorder through midlife5
Cognitive outcomes of the bipolar depression electrical treatment trial (BETTER): a randomized, double-blind, sham-controlled study5
Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 20154
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited4
Mental health status of adolescents after family confinement during the COVID-19 outbreak in the general population: a longitudinal survey4
Differences in single positive formal thought disorder symptoms between closely matched acute patients with schizophrenia and mania4
Specialized inpatient treatment for young people with early psychosis: acute-treatment and 12-month results4
Bridge centrality network structure of negative symptoms in people with schizophrenia4
Classical blood biomarkers identify patients with higher risk for relapse 6 months after alcohol withdrawal treatment4
Prefrontal resting-state connectivity and antidepressant response: no associations in the ELECT-TDCS trial4
Alarmingly large unemployment gap despite of above-average education in adults with ASD without intellectual disability in Germany: a cross-sectional study4
Negative schizotypal traits predict the reduction of reward motivation in effort–reward imbalance4
Assessing the mediating role of impulsivity between methamphetamine-induced psychotic disorders and increased gambling severity in methamphetamine-dependent individuals4
Relationship between childhood maltreatment and cognitive function in medication-free patients with major depressive disorder4
Eye movement indices as predictors of conversion to psychosis in individuals at clinical high risk4
Why do we climb mountains? An exploration of features of behavioural addiction in mountaineering and the association with stress-related psychiatric disorders4
Structural alterations in brainstem, basal ganglia and thalamus associated with parkinsonism in schizophrenia spectrum disorders4
Childhood trauma mediates repetitive transcranial magnetic stimulation efficacy in major depressive disorder4
Immune cell puzzle COVID-19: how do SARS-CoV infections contribute to psychiatric diseases?4
Effects of rhythmic auditory stimulation on upper-limb movement speed in patients with schizophrenia spectrum disorders4
Physical activity, physical self-perception and depression symptoms in patients with major depressive disorder: a mediation analysis4
Rumination mediates the relationship between childhood trauma and depressive symptoms in schizophrenia patients4
Negative symptoms in first episode schizophrenia: treatment response across the 2-year follow-up of the “Parma Early Psychosis” program4
Understanding the neural basis of survival instinct vs. suicidal behavior: a key to decode the biological enigma of human suicidal behavior4
Altered psychobiological reactivity but no impairment of emotion recognition following stress in adolescents with non-suicidal self-injury4
Accelerated atrophy in dopaminergic targets and medial temporo-parietal regions precedes the onset of delusions in patients with Alzheimer’s disease4
Robust perceptual-load-dependent audiovisual integration in adult ADHD4
Neural rhythm in the retrosplenial cortex during ketamine-induced dissociation4
Exploring the course of adolescent anxiety and depression: associations with white matter tract microstructure4
Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes4
Clinical response in patients treated with once-monthly paliperidone palmitate: analysis of a therapeutic drug monitoring (TDM) database4
Links of platelet glutamate and glutathione metabolism with attenuated positive and negative symptoms in depressed patients at clinical high risk for psychosis4
Assessing the links between childhood trauma, C-reactive protein and response to antidepressant treatment in patients with affective disorders4
Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options4
Association between aerobic fitness and the functional connectome in patients with schizophrenia4
Predicting the diagnosis of various mental disorders in a mixed cohort using blood-based multi-protein model: a machine learning approach3
Guideline for schizophrenia: implementation status and attitude toward an upcoming living guideline3
Cognitive and clinical characteristics of offenders and non-offenders diagnosed with schizophrenia spectrum disorders: results of the Recoviwel observational study3
Gender differences in clinical and biochemical parameters among patients hospitalized for schizophrenia: towards precision medicine3
Is the serotonin hypothesis/theory of depression still relevant? Methodological reflections motivated by a recently published umbrella review3
Altered empathy-related resting-state functional connectivity in patients with bipolar disorder3
Atypical local brain connectivity in pediatric autism spectrum disorder? A coordinate-based meta-analysis of regional homogeneity studies3
Increased subcortical region volume induced by electroconvulsive therapy in patients with schizophrenia3
0.04249095916748